Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GMZ2-CAF01 malaria vaccine phase 1 study
PACTR201503001038304Phase 1Unknown
- Sponsor
- Centre de Recherches Médicales de Lambaréné
- Start
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1 trial of PfSPZ Challenge in malaria (5 arms), sponsored by Centre de Recherches Médicales de Lambaréné. Primary endpoint: Primary safety and tolerability endpoint. Status: unknown.
02
Drugs
PfSPZ Challenge
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201503001038304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201503001038304.